
Cefscot-S 375 Injection
Marketer
Scotwin Healthcare
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Cefscot-S 375 Injection
Cefscot-S 375 Injection, a dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation. Administration must be overseen by a medical practitioner; strict adherence to the prescribed dosage schedule is crucial for optimal efficacy. Interrupting treatment prematurely may compromise its effectiveness, so complete the full course even with symptom improvement. Typical side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms require immediate medical attention. Allergic reactions (skin rashes, pruritus, edema, respiratory distress) necessitate prompt medical assistance. Inform your physician of all current medications, especially if pregnant or breastfeeding, before commencing treatment. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, avoid operating vehicles if drowsiness or dizziness occurs. Adequate rest, nutrition, and hydration contribute to faster recovery. Monitoring may involve laboratory tests to assess treatment response.
Uses of Cefscot-S 375 Injection
Infections caused by bacteria
Major Benefits of Cefscot-S 375 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Cefscot-S 375 Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Cefscot-S 375 Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
How Cefscot-S 375 Injection works:
Ceftriaxone and sulbactam, combined as Cefscot-S 375 Injection, offer a dual-action approach to bacterial infections. Ceftriaxone's antibiotic properties disrupt bacterial cell wall synthesis, hindering their ability to thrive. The addition of sulbactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby bolstering Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Concurrent use of alcohol and Cefscot-S 375 Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Cefscot-S 375 is typically deemed safe for use in pregnancy. Preclinical trials in animals revealed minimal or no harmful consequences to the fetus; nonetheless, clinical data from human trials are scarce.
Breast feedingCAUTION
The administration of Cefscot-S 375 Injection to breastfeeding mothers requires careful consideration. Mothers should discontinue breastfeeding throughout the course of treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
Administering Cefscot-S 375 Injection may induce drowsiness, blurred vision, and dizziness. Driving is contraindicated if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding Cefscot-S 375 Injection's use in patients exhibiting renal impairment is scarce. Physician consultation is recommended.
LiverCAUTION
Cefscot-S 375 Injection requires careful administration in individuals with significant hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Dosage alteration for Cefscot-S 375 Injection is not suggested for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Cefscot-S 375 Injection :
Omitting a scheduled dose of Cefscot-S 375 Injection warrants immediate physician consultation.
Facts to Know About Cefscot-S 375 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
